All In Biotech

Drug Trial Radar · NCT00003771

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

Protocol for Randomized Clinical Study Concerning Hormonal Replacement Therapy (HRT) After Previous Radical Breast Cancer Treatment

Last checked: Nov 20, 2026Latest source record: Sep 20, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,300

Planned (sponsor's estimate)

Start

Sep 1997

Primary completion

Not stated

Study completion Feb 2004

Sponsor

Lead sponsor
Regional Oncologic CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Scandinavian Breast Group; ETOP IBCSG Partners Foundation; European Organisation for Research and Treatment of Cancer - EORTC
First posted
Jan 27, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Masking
None
Primary purpose
Supportive care
Who can join
Female only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Hormone replacement therapy is effective for relieving symptoms of menopause. It is not yet known if hormone replacement therapy increases the risk of breast cancer recurrence in women previously treated for early stage breast cancer. PURPOSE: Randomized phase III trial to determine the risk of breast cancer recurrence in women with previous early stage breast cancer who are receiving hormone replacement therapy for menopause symptoms.

Conditions

  • Breast Cancer
  • Menopausal Symptoms

Interventions

  • therapeutic estradiolBiological

  • norethindrone acetateDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

6 sites in 5 countries. Site status is shown where the registry gives one.

  • Helsinki University Central Hospital

    Helsinki, Finland

  • Norwegian Radium Hospital

    Oslo, Norway

  • Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology

    Warsaw, Poland

  • Karolinska Hospital

    Stockholm, Sweden

  • Uppsala University Hospital

    Uppsala, Sweden

  • Breast Center

    Zurich, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.